NuPathe Inc, a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced top-line results from the pivotal phase-III clinical trial of Zelrix, a novel transdermal patch in clinical development for the treatment of acute migraine.
The details can be read here.
No comments:
Post a Comment